Roche Holding AG Participation (RHHVF OTCQX) stock market data APIs
$489.1732
6.42(1.3%)
as of October 30, 2026
Try our APIs with
free plan!
Roche Holding AG Participation Financial Data Overview
Price chart is built with
Anychart
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
Prev. Close
489.1732
Open
495.5968
High
495.6552
Low
486.9667
52 wk Range
313.1472-499.76
Market Cap
386 973 M
P/E Ratio
25.1387
Shares Outstanding
690 M
Revenue
62 959 M
EPS
0
Dividends (Yield)
0.0201
Beta
0.327
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Roche Holding AG Participation (top by weight)
Ticker
100-day Price Change
Weight
RRITX.US
T. ROWE PRICE INTERNATIONAL STOCK FUND T. ROWE PRICE INTERNATIONAL STOCK FUND-R CLASS
-0.34
(-1.54%)
2.22
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roche Holding AG Participation data using free add-ons & libraries
Get Roche Holding AG Participation Fundamental Data
Roche Holding AG Participation Fundamental data includes:
- Net Revenue: 62 959 M
- EBITDA: 23 964 M
- Earnings Per Share: 19
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Roche Holding AG Participation Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-04-23
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roche Holding AG Participation News
New
Novartis (SWX:NOVN) Reports Longer Survival In Advanced Kidney Cancer Trial
Novartis (SWX:NOVN) reported new trial data showing Votrient plus Roche's Avastin improved overall survival in certain advanced kidney cancer patients. The combination delivered overall survival outco...
Roche Holding (SWX:ROP) Expands ADC Pipeline As Late Stage Trial Results Impress
Roche Holding (SWX:ROP) agreed a multi-program Antibody-Drug Conjugate collaboration with Hansoh Pharmaceutical, targeting oncology assets beyond China. The partners plan to co-develop and potentially...
EXEL Q3 Earnings Beat Estimates on Strong Cabometyx Sales
Exelixis EXEL reported better-than-expected results for the third quarter of 2026, with earnings and revenues surpassing the Zacks Consensus Estimate. Adjusted earnings per share (EPS) of 94 cents be...
Global Human Papillomavirus (HPV) Genotyping Panels Market Report 2026 | Capitalize on NGS, AI and Self-Collection Through 2030 with Roche, Abbott, Thermo Fisher and QIAGEN
Company Logo Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Human Papillomavirus (HPV) Genotyping Panels Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global human ...
Get Roche Holding AG Participation fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.